Myelodysplastic Syndrome (Mds): Seeking Cure Through Discovery on Pathogenesis and Disease Progression
The summary for the Myelodysplastic Syndrome (Mds): Seeking Cure Through Discovery on Pathogenesis and Disease Progression Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
| Federal Grant Title: | MYELODYSPLASTIC SYNDROME (MDS): SEEKING CURE THROUGH DISCOVERY ON PATHOGENESIS AND DISEASE PROGRESSION |
| Federal Agency Name: | National Institutes of Health |
| Program Name: | Blood Diseases and Resources Research |
| Grant Categories: | Health |
| CFDA Number: | 93.839 |
| Funding Opportunity Number: | RFA-HL-04-033 |
| Posted Date: | May 24, 2004 |
| Creation Date: | May 24, 2004 |
| Original Application Deadline: | Feb 16, 2005 |
| Current Application Deadline: | Information not provided |
| Archive Date: | Mar 18, 2005 |
| Total Program Funding: | Information not provided |
| Maximum Federal Grant Award: | $350,000 |
| Minimum Federal Grant Award: | Information not provided |
| Expected Number of Awards: | Information not provided |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- County governments State governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses
- Additional Information on Eligibility
- Information not provided
- Grant Description
- This Request for Applications solicits applications that seek new discoveries in the etiology and pathophysiology of myelodysplastic syndromes (MDS) with the aim to develop new and curative treatment options in the future. A separate RFA HL-04-034 (please see http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-04-034.html) is directed towards myeloproliferative disorders. Applicants are directed to apply to one or the other but not both RFAs.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-04-033.html http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-04-033.html
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Erythropoiesis: Components and Mechanisms (R01)
- • Selected Topics in Transfusion Medicine (R01)
- • Selected Topics in Transfusion Medicine (R21)
- • Trans-Agency Research Consortium for Trauma-Induced Coagulopathy (TACTIC) (UM1)
- • Excellence in Hemoglobinopathies Research Award (EHRA) (U54)
- • Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
- • Clinical Hematology Research Career Development Program (K12)
- • Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
- More Grants from the National Institutes of Health
- • Innovative Approaches and Technologies for Examining the Uncultivable Bacteria of the Oral...
- • Research on the Role of Epigenetics in Social, Behavioral, Environmental and Biological Re...
- • Pediatric Critical Care and Trauma Scientist Development Program (K12)
- • Evidence-based Demonstration Projects in Immunization (Admin Supp)
- • Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the...
